Prognos Health is a real-world data (RWD) company that unlocks the power of data to improve health. Prognos offers the leading managed RWD marketplace, accelerating the development and delivery of innovative therapies and improving health outcomes by offering fully integrated and harmonized lab and health records on more than 325 million de-identified patients. Prognos Health's platform provides a comprehensive and integrated view of patient health, enabling researchers, payers, and providers to make better decisions about care.
$23M sweet spot round size
2010
$23M
from 3 investors over 1 rounds
Prognos Health raised $23M on June 4, 2023
Investors: Marshall Wace, Safeguard Scientifics and + 7 Other investors